お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
925525

高度可視化技術の世界市場:成長、動向、予測(2020年~2025年)

Advanced Visualization Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.15円
高度可視化技術の世界市場:成長、動向、予測(2020年~2025年)
出版日: 2020年02月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の高度可視化技術市場は、2020年から2025年の予測期間にわたって11.3%のCAGRで成長すると予想されています。市場の成長の主な要因には、高齢者人口の増加による慢性疾患の有病率の上昇、および疾患診断における高度な視覚化技術の利点への認識の高まりが含まれています。 高齢者人口の増加により、さまざまな慢性疾患に苦しむ患者が増えており、高度可視化技術により正確な診断率が向上することが期待され、市場成長の拡大が見込まれております。

当レポートは世界の高度可視化技術市場について調査しており、市場機会や動向、成長および抑制要因、セグメント別や地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場成長要因
    • 高齢者人口の増加による慢性疾患の有病率の増加
    • 疾患診断における高度な可視化ツールの利点についての認識の高まり
  • 市場抑制要因
    • 放射線医学に基づく診断手順のための償還の限られた可用性
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 競争の激化

第5章 市場区分

  • 製品およびサービス別
    • ハードウェア
    • ソフトウェア
    • サービス
  • ソリューションタイプ別
    • 企業
    • スタンドアロン
  • 画像診断技術別
    • 磁気共鳴画像(MRI)
    • コンピュータ断層撮影(CT)
    • 超音波
    • 核医学
    • その他
  • 臨床応用別
    • 腫瘍学
    • 整形外科
    • 心血管
    • 神経学
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • AGFA-Gevaert NV
    • Canon Medical Systems
    • Carestream Health, Inc.
    • Fujifilm Holdings Corporation
    • GE Healthcare
    • Koninklijke Philips NV
    • PRO Medicus Limited
    • Siemens Healthineers
    • Terarecon, Inc.

第7章 市場機会および将来動向

目次
Product Code: 57051

The advanced visualization market is expected to register a CAGR of 11.3% over the forecast period. The major factors for the growth of the market include the increasing prevalence of chronic diseases coupled with growing geriatric population, and rising awareness of benefits associated with advanced visualization tools in disease diagnosis.

According to the United States Census Bureau's Statistics as of 2017, the total number of people aged 65 and older had exceeded 50 million, and between 2020-2030 the number of elderly people is projected to increase by almost 18 million. Although much smaller in total size, the number of people aged 85 and older is expected to be more than triple from an estimated 6 million currently to nearly 20 million by 2060. The rise in geriatric population will increase the patient pool suffering from various chronic diseases and advanced visualization tools are expected to increase the correct diagnosis rate among the patients. Hence, the market is expected to witness high growth.

Key Market Trends

Oncology Segment by Clinical Application is Expected to Witness High Growth over the Forecast Period

The major factors driving growth of the market includes rising technological advancements and increase in the adoption of the advanced visualization tools in healthcare facilitites. Furhermore, the rising prevalence of various types of cancer is expected to boost the demand for advanced visualization systems over the forecast period. The global cancer burden is increasing, and thus, cancer therapies must be modified according to regional and national priorities. According to the World Cancer Research Fund, in 2018, there were an estimated 18 million cancer cases around the world, out of which, 9.5 million cases were in men and 8.5 million in women.

Also, major market players are launching new products in the market. For instance, in Febrauary 2019, Philips announced the launch of IntelliSpace Portal 11, which is an advanced visualization and quantification software.

Thus, considering all the above mentioned factors the market is expected to witness high CAGR over the forecast period.

North America is Expected to hold a Significant Market Share over the Forecast Period

North America expected to hold a major market share in the global advanced visualization market due to increasing cases of chronic diseases and presence of better healthcare infrastructure. Information systems have tremendous potential in reducing healthcare costs and improving outcomes. These systems play a major role, not only in reducing costs but also in improving the accurate diagnosis. In the United States most of the hospitals are focusing on providing the value-based care. The advanced visualization systems are expected to help healthcare providers to do the same. Hence, the market is expected to witness high growth over the forecast period.

Competitive Landscape

The advanced visualization market is moderately consolidated market. Some of the market players in advanced visualization market are AGFA-Gevaert N.V., Canon Medical Systems, Carestream Health, Inc., Fujifilm Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., PRO Medicus Limited, Siemens Healthineers, and Terarecon, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases Coupled With Growing Geriatric Population
    • 4.2.2 Rising Awareness of Benefits associated with Advanced Visualization Tools in Disease Diagnosis
  • 4.3 Market Restraints
    • 4.3.1 Limited Availability of Reimbursements for Radiology-Based Diagnostic Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product & Service
    • 5.1.1 Hardware
    • 5.1.2 Software
    • 5.1.3 Services
  • 5.2 By Type of Solution
    • 5.2.1 Enterprise
    • 5.2.2 Standalone
  • 5.3 By Imaging Modality
    • 5.3.1 Magnetic Resonance Imaging (MRI)
    • 5.3.2 Computed Tomography (CT)
    • 5.3.3 Ultrasound
    • 5.3.4 Nuclear Medicine
    • 5.3.5 Other
  • 5.4 By Clinical Application
    • 5.4.1 Oncology
    • 5.4.2 Orthopedics
    • 5.4.3 Cardiovascular
    • 5.4.4 Neurology
    • 5.4.5 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AGFA-Gevaert N.V.
    • 6.1.2 Canon Medical Systems
    • 6.1.3 Carestream Health, Inc.
    • 6.1.4 Fujifilm Holdings Corporation
    • 6.1.5 GE Healthcare
    • 6.1.6 Koninklijke Philips N.V.
    • 6.1.7 PRO Medicus Limited
    • 6.1.8 Siemens Healthineers
    • 6.1.9 Terarecon, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.